Critical Cholera Vaccine Research
Sabin partnered with Kenya Medical Research Institute (KEMRI) to optimize the use of the oral cholera vaccine, examining dosing and effective intervals between doses. Funded by the Wellcome Trust, the study aims to inform vaccination strategies that could be beneficial in tackling the global resurgence of cholera as well as acute vaccine shortages.